Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Prevention of Influenza-Related Morbidity and Mortality

Prevention of Influenza-Related Morbidity and Mortality Abstract Barker and Mullooly, in this issue of the Archives (p 85), have characterized the adult patient population at greatest risk for a fatal outcome during influenza epidemics. Results of a survey in Houston (W. P. Glezen, MD, and A. Payne, DPH, unpublished data, Jan 1, 1976, through June 30,1978) are in general agreement with their description, with a few exceptions. During the intense influenza A/Victoria virus epidemic of 1976, we found that, in the judgment of the physician signing the death certificate, 18% of the patients whose deaths were attributed either to pneumonia or influenza or both did not have an underlying condition that made them vulnerable to fatal outcome. Furthermore, 38.6% of the patients dying were younger than 65 years. Therefore, the problem was not confined to the aged and infirmed. But should we limit our concern to the persons who do not survive the yearly onslaught of influenza References 1. Glezen WP: Consideration of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 1980;2:408-420.Crossref 2. Glezen WP, Paredes A, Taber LH: Influenza in children: Relationship to other respiratory agents. JAMA 1980;243:1345-1349.Crossref 3. Kim HW, Brandt CD, Arrobio JO, et al: Influenza A and B virus infection in infants and young children during the years 1957-1976. Am J Epidemiol 1979;109:464-479. 4. Corey L, Rubin RJ, Hattwick MA, et al: A nationwide outbreak of Reye's syndrome: Its epidemiologic relationship to influenza B. Am J Med 1976;61:615-625.Crossref 5. Halsey NA, Hurwitz ES, Meiklejohn G, et al: An epidemic of Reye's syndrome associated with influenza A (H1N1) in Colorado. J Pediatr 1980;97:535-539.Crossref 6. Little JW, Hall WJ, Douglas RG Jr, et al: Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis 1978;118:295-303. 7. Burrows B, Knudson RJ, Lebowitz MD: The relationship of childhood respiratory illness to adult obstructive airway disease. Am Rev Respir Dis 1977;115:751-760. 8. Holland WW, Bailey P, Bland JM: Long-term consequences of respiratory disease in infancy. J Epidemiol Community Health 1978;32:256-259.Crossref 9. Barker WH, Mullooly JP: Influenza vaccination of elderly persons: Reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980;244:2547-2549.Crossref 10. Allison JE, Glezen WP, Tabor LH, et al: Reactogenicity and immunogenicity of bivalent influenza A and monovalent B virus vaccines in high risk children. J Infect Dis 1977;136( (suppl) ):5672-5676.Crossref 11. Herron A, Dettleff G, Hixon B, et al: Influenza vaccination in patients with rheumatic diseases: Safety and efficacy. JAMA 1979;242:53-56.Crossref 12. Wililams GW, Steinberg AD, Reinertsen JL, et al: Influenza immunization in systemic lupus erythematosus: A double-blind trial. Ann Intern Med 1978;88:729-734.Crossref 13. Hodges GR, Davis JW, Lewis HD Jr, et al: Response to influenza A vaccine among high-risk patients. South Med J 1979;72:29-32.Crossref 14. Kumar SS, Ventura AK, VanderWert B: Influenza vaccination in renal transplant recipients. JAMA 1978;239:840-842.Crossref 15. Glezen WP, Couch RB: Interpandemic influenza in the Houston area, 1974-1976. N Engl J Med 1978;298:587-592.Crossref 16. Amantadine: Does it have a role in the prevention and treatment of influenza? A National Institute of Health Consensus Development Conference. Ann Intern Med 1980;92(pt (1) ):256-258.Crossref 17. Van Voris LP, Betts RF, Hayden FG, et al: Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981;245:1128-1131.Crossref 18. Chanock RM, Murphy BR: Use of temperature-sensitive and cold-adapted mutant virus in immunoprophylaxis of acute respiratory tract disease. Rev Infect Dis 1980;2:421-432.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Prevention of Influenza-Related Morbidity and Mortality

Archives of Internal Medicine , Volume 142 (1) – Jan 1, 1982

Loading next page...
 
/lp/american-medical-association/prevention-of-influenza-related-morbidity-and-mortality-XLdfoYYYD4
Publisher
American Medical Association
Copyright
Copyright © 1982 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1982.00340140027005
Publisher site
See Article on Publisher Site

Abstract

Abstract Barker and Mullooly, in this issue of the Archives (p 85), have characterized the adult patient population at greatest risk for a fatal outcome during influenza epidemics. Results of a survey in Houston (W. P. Glezen, MD, and A. Payne, DPH, unpublished data, Jan 1, 1976, through June 30,1978) are in general agreement with their description, with a few exceptions. During the intense influenza A/Victoria virus epidemic of 1976, we found that, in the judgment of the physician signing the death certificate, 18% of the patients whose deaths were attributed either to pneumonia or influenza or both did not have an underlying condition that made them vulnerable to fatal outcome. Furthermore, 38.6% of the patients dying were younger than 65 years. Therefore, the problem was not confined to the aged and infirmed. But should we limit our concern to the persons who do not survive the yearly onslaught of influenza References 1. Glezen WP: Consideration of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 1980;2:408-420.Crossref 2. Glezen WP, Paredes A, Taber LH: Influenza in children: Relationship to other respiratory agents. JAMA 1980;243:1345-1349.Crossref 3. Kim HW, Brandt CD, Arrobio JO, et al: Influenza A and B virus infection in infants and young children during the years 1957-1976. Am J Epidemiol 1979;109:464-479. 4. Corey L, Rubin RJ, Hattwick MA, et al: A nationwide outbreak of Reye's syndrome: Its epidemiologic relationship to influenza B. Am J Med 1976;61:615-625.Crossref 5. Halsey NA, Hurwitz ES, Meiklejohn G, et al: An epidemic of Reye's syndrome associated with influenza A (H1N1) in Colorado. J Pediatr 1980;97:535-539.Crossref 6. Little JW, Hall WJ, Douglas RG Jr, et al: Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis 1978;118:295-303. 7. Burrows B, Knudson RJ, Lebowitz MD: The relationship of childhood respiratory illness to adult obstructive airway disease. Am Rev Respir Dis 1977;115:751-760. 8. Holland WW, Bailey P, Bland JM: Long-term consequences of respiratory disease in infancy. J Epidemiol Community Health 1978;32:256-259.Crossref 9. Barker WH, Mullooly JP: Influenza vaccination of elderly persons: Reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980;244:2547-2549.Crossref 10. Allison JE, Glezen WP, Tabor LH, et al: Reactogenicity and immunogenicity of bivalent influenza A and monovalent B virus vaccines in high risk children. J Infect Dis 1977;136( (suppl) ):5672-5676.Crossref 11. Herron A, Dettleff G, Hixon B, et al: Influenza vaccination in patients with rheumatic diseases: Safety and efficacy. JAMA 1979;242:53-56.Crossref 12. Wililams GW, Steinberg AD, Reinertsen JL, et al: Influenza immunization in systemic lupus erythematosus: A double-blind trial. Ann Intern Med 1978;88:729-734.Crossref 13. Hodges GR, Davis JW, Lewis HD Jr, et al: Response to influenza A vaccine among high-risk patients. South Med J 1979;72:29-32.Crossref 14. Kumar SS, Ventura AK, VanderWert B: Influenza vaccination in renal transplant recipients. JAMA 1978;239:840-842.Crossref 15. Glezen WP, Couch RB: Interpandemic influenza in the Houston area, 1974-1976. N Engl J Med 1978;298:587-592.Crossref 16. Amantadine: Does it have a role in the prevention and treatment of influenza? A National Institute of Health Consensus Development Conference. Ann Intern Med 1980;92(pt (1) ):256-258.Crossref 17. Van Voris LP, Betts RF, Hayden FG, et al: Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981;245:1128-1131.Crossref 18. Chanock RM, Murphy BR: Use of temperature-sensitive and cold-adapted mutant virus in immunoprophylaxis of acute respiratory tract disease. Rev Infect Dis 1980;2:421-432.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Jan 1, 1982

References